Injectable Drug Delivery Market
Latest and updated Injectable Drug Delivery market study with COVID19 impact, offers country-wise market projections, brand share analysis, deep-dive analysis on pre-corona & after corona impact, opportunity assessment, and detailed competitive intelligence section.
Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed
- Report code : PMRREP3774 |
- Industry : Life Sciences & Transformational Health |
- Published On : Mar-2020 |
- Pages : 307 Pages |
- Format :
Rapid adoption of technology has led to sedentary lifestyles across the world. This change in lifestyle is the major factor responsible for the increase in obesity rates, leading to many chronic diseases such as diabetes and cardiovascular disorders. The World Health Organization (WHO) has estimated the growth of chronic disease prevalence to rise by 57% by the end of 2020. With the rise in chronic diseases, there has been a rapid increase in the demand for healthcare systems to focus more on sophisticated drug delivery technology. Furthermore, trends towards safety, efficacy, and patient-friendly products are on the rise. Rising demand for advanced technology to address the increasing demand for routine injectable drugs to treat chronic conditions will boost the growth of the injectable drug delivery market over the coming years.
Improving Patient Compliance and Advantages over Conventional Delivery Systems
Rapid adoption of self-administration of medication that requires frequent doses is rising due to reduced cost as compared to hospital visits. Furthermore self-administration such medication is more convenient for most patients. Convenience of home, ease of use, reduced pain, and safety are some of the advantages of injectable drug delivery. Furthermore, the availability of smart devices that track dosage and time along with other features such as reminders and automatic dose adjustments will further facilitate improved treatment adherence and compliance. The rising need and demand for patient compliance to treatment will drive the growth of the injectable drug delivery market through 2029.
North America and Europe to Global Lead Injectable Drug Delivery Market
North America and Europe contributed maximum share to the global injectable drug delivery market, owing to the rising diagnosis and treatment of chronic diseases in these regions. According to WHO, chronic diseases will increase from 3.78 million in 1990 to an expected 7.63 million by the end of 2020. Increased R&D investments, government initiatives to increase awareness about chronic diseases, and rise in healthcare spending are some of the factors that are driving the growth of the injectable drug delivery market in these regions. However, a significantly large patient pool in the Asia Pacific region will offer potential growth opportunities for players in the injectable drug delivery market.
Competitive Landscape of Injectable Drug Delivery Market
The injectable drug delivery market is a consolidated market, with the top 5 players holding over 65% of the market share in 2018. Collaborations with pharmaceutical product manufacturers remains the main focus of players that offer injectable drug delivery technology alone. However, many players are focused on developing in-house injectable drug delivery platforms to offer unique and cost effective products. Other players are focused on geographical expansion to cater to a larger patient pool, through distribution agreements. For instance, in 2016, Biocon launched its disposable pen product in Japan, which will be distributed by its partner Fujifilm Pharma throughout the country.
Analysts’ Viewpoint
The research report on the injectable drug delivery market provides recommendations, overview of the market, and estimation of market growth over the next decade. A majority of companies are expanding their businesses by acquiring smaller companies and increasing their product portfolios. Based on this trend, market players can target North America and Europe, two regions that will hold substantial share of the global injectable drug delivery market. Cost-effective and readily available drug delivery devices will catalyze the growth of the global injectable drug delivery market. Increased funding toward research & development for drug development will help the market grow at a substantial rate. However, at the same time, regulations are becoming more stringent, leading to increased cost of drug development.
Injectable Drug Delivery Market: Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global injectable drug delivery market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the injectable drug delivery market structure. The market study presents exclusive information about how the injectable drug delivery market will grow during the forecast period of 2019-2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. Other information contains volume analysis, which includes year-wise growth of the injectable drug delivery market during the forecast period. This information can help readers understand the quantitative growth prospects of the injectable drug delivery market for the forecast period.
The study is relevant for service providers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to the macroeconomic factors that are impacting developments in the injectable drug delivery market. It also offers actionable insights based on future trends in the injectable drug delivery market. Furthermore, small businesses and new entrants in the injectable drug delivery market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Key Segments of Injectable Drug Delivery Market
PMR’s study on the injectable drug delivery market offers information divided into six important segments—product, technology, usage, indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories
|
Product |
Technology |
Usage |
|
|
|
|
Indication |
Distribution Channel |
Region |
|
|
|
Key Questions Answered in PMR’s Injectable Drug Delivery Market Report
- Which regions will continue to remain the most profitable regional markets for injectable drug delivery market players?
- Which factors will induce a change in the growth of the injectable drug delivery market during the assessment period?
- What are the different opportunities available for emerging players in the injectable drug delivery market?
- How are supply-side and demand-side drivers impacting the injectable drug delivery market?
- How will changing trends impact the injectable drug delivery market?
- How can market players capture the low-hanging opportunities in the injectable drug delivery market in developed regions?
- Which companies are leading the injectable drug delivery market?
- What are the winning strategies of stakeholders in the injectable drug delivery market to upscale their position in this landscape?
Injectable Drug Delivery Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the injectable drug delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the injectable drug delivery market study include statistics from government healthcare organizations, medicinal journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the injectable drug delivery market, and makes PMR’s projection on the growth prospects of the injectable drug delivery market more accurate and reliable.
Companies covered in Injectable Drug Delivery Market Report
- Eli Lilly and Company
- Biocon
- Becton, Dickinson & Company
- West Pharmaceutical Services, Inc.
- Johnson & Johnson
- Antares Pharma
- AbbVie Inc.
- Pfizer Inc.
- Mylan N.V.
- Vetter Pharma-Fertigung GmbH & Co.KG
- Emperra GmbH
- Digital Medics Pty Ltd
- Enable Injections LLC
- Insulet corporation
- Consort Medical Plc
- Diabnext
- Diamesco Co., Ltd
- SCHOTT AG
- SiO2 Medical Products
- Integrity Bio, Inc.
- Wilhelm Haselmeier GmbH & Co. KG
- Tandem Diabetes Care
- Sanofi S.A.
- Companion Medical Inc.
- Ypsomed
- Hoffman - La Roche Ltd.
- Novo Nordisk A/S
- Medtronic Plc.
